Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.

Zetterlund, Linda; Celebioglu, Fuat; Axelsson, Rimma; de Boniface, Jana; Frisell, Jan

Zetterlund, Linda; Celebioglu, Fuat; Axelsson, Rimma; de Boniface, Jana; Frisell, Jan.

Affiliation

Zetterlund L; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. linda.holmstrand-zetterlund@sll.se.
Celebioglu F; Department of Surgery, Södersjukhuset, Stockholm, 118 83, Sweden. linda.holmstrand-zetterlund@sll.se.
Axelsson R; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
de Boniface J; Department of Surgery, Södersjukhuset, Stockholm, 118 83, Sweden.
Frisell J; Department of Clinical Science, Intervention and Technology, Division of Radiography, Karolinska Institutet, Stockholm, Sweden.

Breast Cancer Res Treat ; 163(1): 93-101, 2017 05.

Article in En | MEDLINE | ID: mdl-28213781

Subject(s)

Breast Neoplasms/pathology; Breast Neoplasms/therapy; Lymph Node Excision/methods; Sentinel Lymph Node Biopsy/methods; Adult; Aged; Axilla; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy; Sensitivity and Specificity; Sweden; Young Adult

Key words

Breast cancer; False negative rate; Identification rate; Neoadjuvant systemic therapy; Pre-treatment; Sentinel lymph node biopsy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Sentinel Lymph Node Biopsy / Lymph Node Excision Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Breast Cancer Res Treat Year: 2017 Type: Article Affiliation country: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google